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Abstract
The prevalence of obesity in the United States continues to rise, increasing individual vulnerability 
to an array of adverse health outcomes. One factor that has been implicated causally in the 
increased accumulation of fat and excess food intake is the activity of the limbic-hypothalamic-
pituitary-adrenal (LHPA) axis in the face of relentless stressor exposure. However, translational 
and clinical research continues to understudy the effects sex and gonadal hormones and LHPA axis 
dysfunction in the etiology of obesity even though women continue to be at greater risk than men 
for stress-induced disorders, including depression, emotional feeding and obesity. The current 
review will emphasize the need for sex-specific evaluation of the relationship between stress 
exposure and LHPA axis activity on individual risk for obesity by summarizing data generated by 
animal models currently being leveraged to determine the etiology of stress-induced alterations in 
feeding behavior and metabolism. There exists a clear lack of translational models that have been 
used to study female-specific risk. One translational model of psychosocial stress exposure that 
has proven fruitful in elucidating potential mechanisms by which females are at increased risk for 
stress-induced adverse health outcomes is that of social subordination in socially housed female 
macaque monkeys. Data from subordinate female monkeys suggest that increased risk for 
emotional eating and the development of obesity in females may be due to LHPA axis-induced 
changes in the behavioral and physiological sensitivity of estradiol. The lack in understanding of 
the mechanisms underlying these alterations necessitate the need to account for the effects of sex 
and gonadal hormones in the rationale, design, implementation, analysis and interpretation of 
results in our studies of stress axis function in obesity. Doing so may lead to the identification of 
novel therapeutic targets with which to combat stress-induced obesity exclusively in females.
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Introduction
Rates of obesity in the United States (US) continue to rise, with recent 2014 estimates 
placing the prevalence at 38% of the population [1], which is expected to increase to 50% by 
2030 [2]. Importantly, obesity is a significant risk factor for a number of adverse health 
outcomes including type II diabetes, cardiovascular disease, stroke, some types of cancers, 
reproductive compromise, and musculoskeletal problems [3, 4]. Despite significant medical 
advances for managing these somatic illnesses, obesity-related disorders account for nearly 
112,000 excess deaths in the US [5]. For these reasons, understanding the factors that 
produce an obese phenotype is critical for identifying interventional strategies that reduce 
the health burden imposed by obesity and obesity-related adverse health outcomes.
Obesity is primarily attributed to excess caloric intake beyond the energetic needs of an 
organism. Factors that promote eating while an individual is satiated have recently gained 
attention as potential interventional targets. For instance, exposure to chronic psychosocial 
stressors in a dietary environment wherein calorically dense diets (i.e. high in fats and 
sugars; CDD) are available results in stress-induced emotional eating and increased body 
weight [6]. The physiological response of the limbic-hypothalamic-pituitary-adrenal (LHPA) 
axis in response to chronic stressor exposure results in glucocorticoid secretion from the 
adrenals, and release of cortisol promotes the consumption of extra calories and, over a long 
enough period of time, weight gain [7]. In humans, increased waist-to-hip ratios (WHR) and 
sagital diameter are associated with diminished glucocorticoid negative feedback inhibition 
of the LHPA axis as assessed by a dexamethasone suppression test [8], increased cortisol 
reactivity to a stressor [9], and blunted morning cortisol levels [10, 11].
The earliest indication that increased activity of the LHPA axis results in an obese phenotype 
comes from our characterization of excess glucocorticoids and increased visceral fat in 
Cushing’s Disease [4, 12]. The causal role for glucocorticoids in promoting food intake and 
weight gain was cemented by studies in rodents [13–15] and humans wherein administration 
of exogenous glucocorticoids resulted in augmented abdominal obesity [16, 17]. While 
exogenous glucocorticoid administration clearly results in weight gain, the effects of stress-
induced LHPA dysregulation on “comfort food” intake and energy balance are not consistent 
across animal models [18] and humans [19]. Factors including type and duration of stressor, 
methods of LHPA assessment, and dietary environment all influence the effects of stress 
exposure and LHPA axis activity on food intake and metabolism [18, 19].
One important factor that continues to be understudied in the realm of obesity and LHPA 
axis dysfunction is sex. Some studies in rodents and in women indicate that females are 
protected from diet-induced obesity, insulin resistance, and inflammation in response to a 
CDD [20], suggesting that ovarian hormones such as estradiol may be an important 
protective factor against obesity in women. However, other reports indicate that women are 
twice as likely as men to suffer from stress-induced disorders, including depression, anxiety, 
emotional feeding and obesity [21–27]. This discrepancy in the risk for obesity in females 
may be due to the disregard of addressing how exposure to stressors and dysregulation of the 
LHPA axis may alter the behavioral and physiological sensitivity of gonadal hormones in 
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females, thus increasing risk for adverse health outcomes such as emotional eating and 
obesity.
The current review will summarize the literature from translational animal research 
describing the effects of stressor exposure and LHPA axis activity on appetite regulation and 
the development of obesity, while concurrently emphasizing the overall lack of animal 
models and studies addressing the etiology of stress-induced obesity specifically in females. 
A non-human primate model of chronic psychosocial stress exposure will be discussed to 
emphasize how stressor exposure may alter sensitivity to estradiol (E2), the primary ovarian 
hormone, thereby increasing risk for adverse health outcomes, including emotional eating 
and fat accumulation. Lastly, potential mechanisms by which stressor exposure and LHPA 
axis function lead to such phenotypes in females will be considered.
Translational Rodent Models Used to Study Stress-induced Obesity Have 
studied Males Almost Exclusively
A stressor is any perceived threat that jeopardizes the well being of an organism and induces 
physiological changes that activate systems crucial for surviving the perceived stressor and 
returning back to baseline homeostasis [28, 29]. Stressors can be physical or psychological 
in nature, can be discrete events or continuous assaults on homeostasis, and can have both 
physiological and behavioral consequences for an individual organism [30]. The rapid 
activation of the sympathetic nervous system and the LHPA axis in response to a threat 
likely evolved to promote survival from acute physical stressors [28, 30]. However, stress 
exposure in modern day human societies increasingly takes the form of psychological 
stressors that are experienced on a daily basis [30]. Continuous activation of the LHPA axis 
under such conditions is deleterious to individual health as evidenced by the increase of 
disorders whose etiology stems from a dysregulation of LHPA neuroendocrine circuits, 
including obesity [29, 30].
One approach undertaken to emulate the downstream effects of chronic stress has been 
exogenous administration of high levels of glucocorticoids. While these studies do not 
subject animals to actual physical or emotional stressors, they mimic elevated levels of 
corticosterone that are associated with chronic exposure to stressors in rodents [31–33]. 
Chronic corticosterone administration via drinking water in male rats over three weeks 
disrupts endogenous adrenocorticotropic hormone (ACTH), corticosterone and glucose 
levels [34]. Administration of exogenous glucocorticoids in male rodents also results in 
augmented abdominal obesity under dietary conditions wherein only a prudent, low calorie 
chow diet (LCD) is available [13, 15], as well as when a CDD is offered exclusively [14]. 
These data from male rodents recapitulate increases in weight and adiposity due to 
exogenous glucocorticoid treatment in humans [16, 17]. However, data generated from these 
glucocorticoid manipulations should be interpreted with caution as the manipulation results 
in the loss of the normal diurnal glucocorticoid rhythm that has been shown to be 
dysregulated in other stress models as well as in human psychopathology [35–37]. 
Furthermore, chronic exogenous corticosterone administration leads to adrenal atrophy [34], 
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which is contrary to the adrenal hypertrophy that has been reported in other animal models 
wherein subjects are exposed to chronic stress [38].
Repeated immobilization or restraint stress is another common model for chronic stress 
exposure in rodents. Animals are placed in plastic tubes that immobilize their lateral and 
forward movement, typically for 30 minutes a day, for seven consecutive days [39, 40]. 
Daily restraint increases coticosterone levels after subsequent bouts of restraint as well as 
ACTH levels in male rodents [41]. Male rats that undergo chronic restraint under conditions 
wherein LCD is available show alterations in metabolic phenotype, including an attenuation 
of body weight [40]. More recently however, the chronic restraint model in male rats has 
been critical for studying how dietary environment and access to CDD interacts with stress 
exposure to alter feeding behavior and metabolism [42, 43]. These studies indicate that 
elevation of glucocorticoids in the presence of CDD shifts the dietary preference towards 
intake of these comfort foods in the face of stressor exposure [42, 43], similar to what is 
described in humans [44].
A different model of physical chronic stress exposure in rodents is chronic intermittent cold 
stress exposure wherein animals are subjected to a few hours a day of low temperatures 
ranging from 4–6°C, for a week. This chronic intermittent cold stress model has been critical 
in elucidating, via neurochemical, neuroanatomical, and lesion studies, the underlying 
circuits that are activated by acute stress superimposed on a background of chronic cold 
stress in male rats [45, 46]. Additionally, this cold chronic stressor has been used to 
determine how adrenalecotomy, and thus glucocorticoids, interact with a chronic stress 
background to modulate the activity of the LHPA axis in response to subsequent stressors in 
male rats [47]. Importantly, chronic intermittent cold stress exposure in parallel with access 
to only a LCD increases food intake and fat deposits in male rodents [31].
While the above mentioned physiological and physical stress paradigms have been leveraged 
to understand the effects of chronic stress on the emergence of an obese phenotype, these 
models in male rodents induce physiological and behavioral responses that are exclusive to 
the stressor employed in the model. Animals subjected to these physiological and physical 
procedures adapt to stressor exposure, such that they habituate and show attenuated HPA 
responses to stressor exposure or a faster return to baseline conditions, or they stop eliciting 
hormonal and behavioral responses to the stressor [45, 48–52]. Paradigms and models 
wherein the chronic stressor exposure is both unpredictable and uncontrollable results in 
continued activation of behavioral and physiological responses to stress, similar to what has 
been described in humans. Such translational animal models have been studied to assess the 
effects of chronic psychosocial stress exposure on appetite regulation and the emergence of 
obesity.
Several rodent models of chronic stress have been employed to assess the effects of LHPA 
axis dysregulation on the emergence of an obese phenotype by using psychosocial stressors 
that mimic human experiences. For instance, the chronic variable stress (CVS) paradigm 
exposes rats to six weeks of repeated mild physical (restraint, home cage tilt, cold stress) and 
psychosocial stressors (social isolation) [53]. CVS results in increased basal corticosterone 
and ACTH, as well as increased adrenal size and alterations in neurobiological markers of 
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LHPA axis function [53]. Overall, the dysfunction within the LHPA axis due to CVS 
exposure is associated with altered behavioral phenotypes, including deficits in fear learning, 
emotional arousal in male rats [54] and anhedonia in both female and male rats [55, 56]. 
Furthermore, female rats subjected to CVS show altered appetite regulation and metabolism 
in a dietary condition wherein only a CDD was available [57]. CVS-subjected females on a 
CDD eat significantly less calories that control females in the same CDD diet condition, and 
do not show an increase in weight that was seen in control animals [57]. While these data 
suggest that CVS in females attenuates caloric intake and body weight and adiposity 
increases compared to control animals in a CDD environment, the lack of a stress-effect seen 
in other studies may be due to the fact that females in this study were not given a dietary 
choice [57]. Indeed, previous rodent data has shown that the presence of a dietary choice 
condition, wherein both a LCD and CDD are available, sustains intake of high caloric diets 
[58].
An ethological social stressor is also employed in two other rodent models of psychosocial 
stress exposure used to assess the effects of LHPA axis activity on food intake and the 
emergence of obesity. The social defeat model in male rodents (rats and hamsters) 
repeatedly exposes an animal to a more aggressive intruder on a single day. This social 
defeat results in the subordination of the socially defeated male rats and hamsters, and 
produces sustained activation of the LHPA axis [59, 60], immune dysfunction [61] and 
specific changes in neurochemical circuits within mesolimbic regions [60, 62]. Behaviorally, 
social defeat in male rodents is associated with anhedonia, decreased activity, and increased 
depressive-like behaviors [60]. Additionally, socially defeated male hamsters that only have 
access to a LCD increase food intake, body mass, and white adipose tissue [62, 63].
The visible burrow system (VBS) is another rodent model of psychosocial stressor exposure 
used to study the effects of stress exposure on food intake wherein groups of male rats are 
housed socially with several females for two weeks [64]. A dominance hierarchy is formed 
immediately between males within the VBS, and the subordinate males behavioral and 
physiological phenotypes characteristic of chronic stress exposure. For example, subordinate 
males have increased basal corticosterone levels and enlarged adrenal glands [65]. In dietary 
conditions wherein only a LCD is available, subordinate males have attenuated body weight 
that is attributable to decrease adipose tissue that results in hypoleptinemia [65–68]. 
However, when animals are given intermittent recovery periods from social housing during 
which previously subordinate males respond differently than dominant males, most typically 
with excess food intake and weight gain when maintained on a LCD only [67, 69].
Together, the CVS, social defeat, and VBS models of chronic stress exposure employ 
psychosocial adversity similar to those experienced by humans that results in physiological 
and behavioral phenotypes characteristic of adverse chronic-stress states in people. The data 
generated from these rodent models have significantly advanced our understanding of how 
chronic exposure to social stressors and LHPA dysregulation produce changes in appetite 
and metabolism that contribute to obesity. However, while these models employ a repeated 
uncontrollable or unpredictable type of stressor, face and construct validity is diminished 
because the stressor is discontinued. Furthermore, only one of the rodent models described 
above has been used to exclusively assess the effects of stress and LHPA axis activity on 
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feeding behavior in females. While some models are limited due to the ethological nature of 
the stressors, such as the VBS that only produces male dominant and subordinate rats [65–
68], the other rodent models discussed have studied male rodents [42, 45]. The CVS rodent 
model of unpredictable chronic stress exposure is one of the few rodent models that have 
been used to study sex differences in the development of the responses to CVS and the 
underlying mechanisms that might be responsible for these differences [57, 70].
The consideration of sex is critical in our studies of the stress axis and obesity, as women 
exposed to stress are more likely to increase food intake compared to men [21, 71]. Studies 
in women have shown that females who show a greater cortisol response to an acute stressor 
also exhibit increased caloric intake after stressor exposure [72]; a similar result has been 
reported in female rhesus monkeys [73]. Furthermore, this increased cortisol response to a 
stressor in women has been linked to greater amount of central fat mass [9] that is also 
associated with increased urinary free cortisol levels [74]. Obese women who gain weight 
following a stressful event show significantly higher levels of urinary free cortisol than 
women who have nonstress-related obesity [75]. Augmented urinary free cortisol levels in 
obese women are also associated with increased intake of CDD [76], supporting the notion 
that increased LHPA axis activity following exposure to acute psychosocial stressors in 
women shifts dietary preferences such that CDD are preferred [71, 72]. These clinical data 
highlight the need to study the interaction of obesity and LHPA axis activity in a sex-
dependent manner, and as such, more robust, translational animal models in females are 
necessary.
Social Subordination in Female Macaques is an ethologically relevant 
translational model with which to study Stress-induced Obesity in Females
One translational model of psychosocial stress exposure in females that is characterized by 
constitutive exposure to adverse social environment, similar to that experienced by people 
and implicated in the development of stress-induced disorders, is that of social subordination 
in socially housed female macaque monkeys [77]. Macaque social groups are organized by a 
linear dominance hierarchy that is imposed by the threat of aggression or harassment from 
higher-ranking individuals towards lower-ranking individuals within the hierarchy [78, 79]. 
Subordinate social status in female macaques results in an array of adverse health outcomes 
that mimic those seen in humans [80] (summarized in Table 1), such as a pro-inflammatory 
state [81]. Importantly, subordination in female macaques is associated with alteration in 
LHPA axis activity [82, 83], including hypercortisolemia due to diminished glucocorticoid 
negative feedback of the LHPA axis [84, 85], altered sensitivity to ACTH [82, 86], and 
increased adrenal size [87].
The dysregulation of the LHPA axis in subordinate females is coincident with augmented 
caloric intake when a CDD is made available in a choice diet condition wherein a LCD is 
also available [73]. This hyperphagia in the presence of a CDD is associated with increased 
meal and snack size [88], an increase in body weight after three weeks of CDD availability, 
and a decrease in anxiety-like behavior in subordinate females [35]. CDD availability in 
female rhesus monkeys results in increased basal cortisol levels, regardless of social status 
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[35, 73]. Similarly, intake of CDD increases LHPA axis activity in rodents [89–91] and in 
humans [8]. In a more recent study, administration of a CRH receptor antagonist attenuated 
overall caloric intake in subordinates [92], indicating that stress-induced emotional eating in 
subordinate females with access to both a low calorie diet and CDD is sustained by LHPA 
axis activity.
Importantly, the social subordination model in female macaques has also been leveraged to 
assess how exposure to chronic stress alters behavioral and physiological sensitivity to E2. 
E2 replacement in ovariectomized monkeys increases basal levels of glucocorticoids as well 
as diminishes negative feedback inhibition of the LHPA axis [84]. Exposure to social 
subordination in female monkeys further enhances the escape from glucocorticoid negative 
feedback [84], indicating that E2 and stress exposure can synergize to influence activity of 
the LHPA axis. This altered sensitivity to E2 on LHPA axis function in subordinate females 
is coincident with a decreased behavioral sensitivity to the anxiolytic actions of E2, as 
replacement of E2 to ovariectomized subordinate monkeys does not reduce levels of anxiety-
like behaviors as effectively as E2 does in dominant females [93].
Another documented alteration in physiological sensitivity to E2 that has been observed in 
subordinate monkeys relates to E2 modulation of the hypothalamic-pituitary-gonadal (HPG) 
axis. Subordinate females show enhanced E2 inhibition of the HPG axis that results in 
attenuated luteinizing hormone (LH) levels [94]. This altered HPG sensitivity in subordinate 
females is exacerbated by pharmacological increases in cortisol levels [94], suggesting that 
the increased incidence of anovulation and luteal phase deficiency seen in subordinate 
versus dominant females is due to sustained LHPA axis activity in subordinate females [95, 
96]. Together, these data indicate that exposure to chronic stressors alters physiological 
sensitivity to E2 in subordinate females, suggesting that a similar alteration in sensitivity to 
E2 may influence the regulation of feeding behavior and increase risk for obesity under 
complex dietary conditions.
E2 is typically considered an anorexic hormone [97, 98], as food intake during the follicular 
phase of the menstrual cycle, wherein E2 levels are high in women, is attenuated in 
comparison to the luteal phase of the cycle [99–102]. Similarly, E2 replacement in 
ovariectomized adult rhesus monkeys to serum levels characteristic of the follicular phase 
significantly reduces meal size and number [98]. However, this anorectic effect of E2 is diet 
dependent, as it is only seen when animals are fed a LCD [98]. When female monkeys are 
maintained in a dietary environment where both a LCD and CDD are available, E2 does not 
attenuate total caloric intake [98] and increases preference for the CDD [98]. Additionally, 
this effect of diet on E2’s modulation of food intake and preference seems to be dependent 
on social status, as E2 in dominant females attenuates food intake whereas it increases 
overall caloric intake in subordinate females [98]. While these data from adult female 
monkeys support the notion that chronic stress alters the ability of E2 to regulate food 
intake, thus increasing the risk for obesity in females, the mechanisms by which this occurs 
remain unclear.
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Possible mechanisms by which stress exposure alters E2’s actions of food 
intake and metabolism
Opposing Actions of Glucocorticoids and Estradiol on Regulators of Metabolism and Food 
Intake
Glucocorticoids, including cortisol and corticosterone, drive downstream alterations in 
metabolic signaling that can lead to increases in food intake and adiposity that are both 
consistent with an obese phenotype (Figure 1). The actions of both peripheral and 
hypothalamic signals that interact to modulate feeding behavior are disrupted by 
glucocorticoids. Exposure to stressors and elevation in glucocorticoids lead to concomitant 
increases in peripheral levels of ghrelin [103–105]. Ghrelin is secreted from the stomach and 
typically acts as an orexigenic peptide [106] via facilitating the hypothalamic actions of 
neuropeptide Y (NPY) and agouti-related protein (AGRP) [107]. Glucocorticoid action 
following exposure to stress can also directly stimulate NPY release from sympathetic 
nerves that acts to increase both NPY and NPY receptor expression on adipocytes whose 
actions facilitate fat growth [108]. This mechanism of fat storage is dependent on increased 
lipoprotein lipase (LPL) activity within visceral fat [4], and acts as a feed-forward loop to 
augment the accumulation of abdominal fat [108] characteristic of obesity [4]. This 
glucocorticoid-induced increase in body fat also results in the augmented secretion of 
adipokines, such as interleukin-6 (IL-6) and tumor necrosis factor α (TNFα), from 
adipocytes that are involved in the development of insulin resistance [109].
Glucocorticoids also potentiate the orexigenic actions of hypothalamic melanin-
concentrating hormone (MCH) [110] and weaken the actions of anorectic signals. For 
instance, excess glucocorticoids can lead to insulin resistance indirectly by increasing 
glucose production from the liver and decreasing glucose uptake by skeletal muscle [111]. 
The overall increase in peripheral glucose levels leads to augmented insulin release from the 
pancreas that with time manifests as insulin resistance [111]. Hyperinsulinemia is a cardinal 
phenotype of obesity that can also lead to dysregulation of leptin signaling in adipocytes that 
normally acts to suppress secretion of insulin from the pancreas [112]. Leptin signaling from 
adipocytes serves as peripheral satiety signal and chronic elevated levels of glucocorticoids 
can lead to hyperleptinemia as well as to leptin resistance [113], both phenotypes associated 
with obesity [114].
The arcuate nucleus of the hypothalamus as well as the paraventricular nucleus (PVN) 
express high levels of glucocorticoid receptors (GRs) [115, 116] by which cortisol and 
corticosterone mediate central effects of stress exposure on food intake [117]. The cellular 
mechanisms by which glucocorticoids act via GRs to impair insulin and glucose 
homeostasis is reviewed elsewhere [118]. However, the actions of peripheral GRs are also 
necessary for the development of stress-induced obesity, as mice lacking adipocyte GR 
expression are resistant to developing obesity in a CDD environment [119]. Thus, 
glucocorticoid resistance coincident with hypercortisolemic conditions, such as obesity and 
depression, may further exacerbate glucocorticoid mediated increases in body fat and release 
of inflammatory adipokines.
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In contrast to the actions of glucocorticoids on food intake and metabolism, E2 attenuates 
food intake and prevents the development of obesity and insulin resistance (Figure 1) [120]. 
Studies in rodents [121], non-human primates and women have all showed that E2 is 
anorectic and increases energy expenditure and activity levels. More specifically, E2 
suppresses lipogenesis in adipocytes by decreasing the activity of LPL, increases lipolysis 
via stimulation of hormone-sensitive lipase (HSL) [122], and suppresses glucose production 
in the liver [123]. Indeed, when E2 levels are low, visceral fat accumulates in females [124], 
via the actions of E2 receptors (ERs) expressed in adipose tissue [125]. Both estrogen 
receptors (ER) α (ERα) and β (ERβ) are expressed in human visceral adipose tissue [126], 
and genetic polymorphisms and deletions of the ERs are associated with increased risk for 
obesity in humans [127] and in rodents [128]. Not only does E2 also facilitate insulin-
induced update of glucose in skeletal muscle but also via both ER α and ERβ mechanisms in 
the pancreas that facilitate the regulation of insulin synthesis and release (reviewed in [122]).
Importantly, E2 also acts to facilitate the actions of anorexigenic signals and attenuate the 
actions of orexigenic molecules. More specifically, expression and secretion of 
hypothalamic NPY is attenuated by E2 [129, 130]. The actions of ghrelin and MCH to 
stimulate food intake are similarly decreased in with E2 replacement in ovariectomized 
rodents [131, 132]. Other translational rodent research indicates that E2 also increases the 
anorectic actions of leptin while concurrently increasing insulin sensitivity via augmenting 
expression of insulin receptors in adipose tissue, and promoting the accumulation of 
subcutaneous over visceral fat mass [133]. Leptin receptors are co-localized with ERs in the 
arcuate nucleus of the hypothalamus indicating a direct mechanism by which E2 increases 
leptin sensitivity [134]. More recently it was shown in female rodents fed a CDD that E2 
decreases diet-induced hypothalamic neurogenesis of leptin-sensitive neurons in the arcuate 
[135]. A similar study showed that E2 administration in ovariectomized mice normalizes the 
decreased insulin sensitivity associated with four weeks of HFD exposure [136]. E2 
replacement in ovariectomized mice has also been shown to decrease the expression of 
TNFα, LPL, and fatty acid synthase in adipocytes [137], all effects consistent with 
decreased fat accumulation and food intake.
Taken together, these data suggest that the effects of E2 on food intake and metabolism are 
typically opposite those of glucocorticoids on these same central and peripheral systems 
(Figure 1). However, under conditions of chronic stress exposure and concomitant LHPA 
dysregulation, the beneficial effects of E2 on these systems may be lost or even reversed, 
such that the actions of E2 may facilitate those of glucocorticoids. One mechanism by this 
may occur is via changes in sensitivity and expression of central and peripheral ERs [122]. 
ERα and ERβ are expressed in the hypothalamus of rodents, with ERα expressed 
predominantly in the arcuate nucleus and ERβ expressed predominantly in the PVN [138]. 
The direct role of ERs on the anorectic effects of E2 are highlighted by data showing that the 
selective knock down or ERα in the hypothalamus of mice increases hyperphagia and fat 
accumulation [139], and that the anorectic effects of E2 are diminished in the presence of 
ERβ oligodeoxynucleotides [140]. Importantly, corticosterone treatment in rodents increases 
ERβ in the PVN [141], suggesting that exposure to chronic stressors and conditions of 
hypercortisolemia can site-specifically alter ER expression. In humans suffering from major 
depressive and bipolar disorder, ERα co-localization with CRH in the PVN that is normally 
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very low to nonexistent, is increased [142]. While these data suggest that stress may alter the 
expression, and thus the function, of ERs to increase risk for obesogenic physiology and 
behavior in females, more studies are necessary to further test this hypothesis.
Alterations in Reward Pathways
Another mechanism by which chronic stressor exposure may increase risk for obesity in 
women is via modulation of reward circuitry and neurochemistry, as mesolimbic dopamine 
signaling is critical to the rewarding aspects of food intake [143]. The underlying 
mechanism by which stress exposure influences reward pathways revolves around signals 
from the stress axis, including CRH, that decrease dopamine (DA) levels within prefrontal 
regions and increase DA in the nucleus accumbens [144] by acting upon dopaminergic 
neurons in mesocortical regions [145–147]. The effects of CRH on DA levels can also 
decrease mesolimbic dopamine 2 receptor (D2R) levels [148]. Decreases of D2R have been 
linked to anhedonia and increased risk for developing an addictive phenotype [149–151], 
including compulsive eating [152]. Socially subordinate female monkeys also show reduced 
levels D2R binding potential (BP) assessed by positron emission tomography (PET) [85, 86, 
153, 154] that are coincident with decreased estimates of central DA release [86, 155] and 
increased rates of cocaine self-administration [154].
A reduction in D2R levels is characteristic to both psychostimulant abuse [156, 157] and 
diet-induced obesity [158–161]. It has been proposed that the attenuation of striatal D2R 
binding may increase susceptibility to drug abuse, as this hypodopaminergic state is thought 
to reflect a reward deficiency syndrome [162]. The notion that stress-induced emotional 
eating is a form of addiction is not new [163], as this form of eating represents an attempt to 
stimulate a hypodopaminergic reward system by intake of CCDs [164–166]. Importantly, 
women are at higher risk for cocaine addiction [167], just as they are more vulnerable to 
increased caloric intake and obesity [21, 71]. Translational data from rodent models indicate 
that E2 stimulates striatal DA release [168, 169] and transiently decreases D2R availability 
[170–172]. This effect of E2 on the dopaminergic system in females is linked to an increased 
propensity to self-administer cocaine [173, 174]. While these data from translational rodent 
work suggest that E2 may increase motivation to ingest CDDs similar to its enhancing 
motivational effects of E2 on cocaine abuse in women, it remains to be determined whether 
exposure to chronic stress exacerbates the effects of E2 on reward pathways to drive stress-
induced intake of CDDs in females.
Conclusions
In summary, the increased risk for obesity in females may be due to chronic stress-induced 
alterations in the behavioral and physiological effects of E2. However, to further delineate 
the mechanisms by which women are more vulnerable to the development of obesity, 
translational and clinical research must be expanded to systematically address the effects of 
sex and gonadal hormones in the etiology of stress-induced disorders [175]. The value of 
such translational animal work is exemplified by the body of work summarized in Table 1 
describing the effects of social subordination on health-related phenotypes in female 
macaques. Taken together, these data from female macaques suggest that chronic 
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psychosocial stress exposure alters sensitivity to E2 thereby increasing risk for adverse 
health outcomes in females. It is also important to study these questions throughout 
development and adulthood, as stress-induced emotional eating occurs in girls [176–178], 
and results in higher rates of obesity [179–182], particularly in girls [176–178]. Accounting 
for sex and gonadal hormones in our examination of stress axis function in obesity will offer 
clarity on the complex relationship, as well as yield novel targets for alleviating the adverse 
consequences of obesity specifically in females.
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Figure 1. 
Opposing actions of glucocorticoids (cortisol) and estradiol on regulators of metabolism and 
food intake. Exposure to chronic stress and dysregulation of the LHPA axis may result in the 
loss and/or reversal of the protective effects of E2 on metabolism and food intake.
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Table 1
Summary of phenotypes associated with social subordination in female rhesus macaques, including altered 
behavioral and physiological sensitivity to estradiol (E2). Significant differences in summarized phenotypes 
between dominant (Dom) and subordinate (Sub).
Phenotype Description References
LHPA Axis
 Glucocorticoid negative feedback Dom > Sub [84–86]
 Basal cortisol levels Sub > Dom [84, 85]
 Adrenal Size Sub > Dom [86]
HPG Axis
 Reproductive deficits Sub > Dom [95, 96]
 E2 negative feedback of HPG axis Sub > Dom [94]
 Oxytocin levels Dom > Sub [93]
Food intake
 Standard LCD Sub ~ Dom [35, 73]
 Choice Condition Sub > Dom [35, 73, 83]
 Anorectic effects of E2 during choice condition Sub < Dom [98]
Metabolic Characteristics in LCD Condition
 Body Weight Dom > Sub [80]
 Body Fat Dom > Sub [80]
 Bone Mass Dom > Sub [80]
 Leptin levels Dom > Sub [80]
Inflammation
 Inflammatory gene expression Sub > Dom [81]
Behavior
 Aggression Emitted Sub < Dom [78, 79]
 Submission Emitted Sub > Dom [80]
 Affiliation Received Sub < Dom [93]
 Anxiolytic effects of E2 Sub < Dom [93]
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